Yüklüyor......
Case report: Bilateral uveitis and papillitis secondary to treatment with pembrolizumab
Pembrolizumab is a programmed cell death protein 1 (PD-1) monoclonal antibody used in the treatment of metastatic melanomas. Severe ocular complications appear in less than 1% of the patients and require early treatment. We present the case of a patient diagnosed with a BRAF mutated metastatic melan...
Kaydedildi:
| Yayımlandı: | Indian J Ophthalmol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer - Medknow
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6896544/ https://ncbi.nlm.nih.gov/pubmed/31755465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijo.IJO_1161_19 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|